echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Could Alzheimer's disease be detected 15 years earlier?

    Could Alzheimer's disease be detected 15 years earlier?

    • Last Update: 2022-04-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Global Burden of Disease figures show that in 2019, there were 57.


    The neurodegenerative conditions that lead to dementia, especially Alzheimer's disease, are often progressive, developing decades before the patient becomes disabled


    What manifestations might be red flags long before Alzheimer's disease is clearly present? To confirm this, a multidisciplinary team from the Paris Brain Institute conducted a large study that analyzed the health records of nearly 80,000 patients


    The team found that compared with other patients of the same age, patients who reported Alzheimer's disease had 10 symptoms more frequently in the 15 years before diagnosis, and another 12 symptoms were more common in the 2 years before diagnosis


    Screenshot source: The Lancet Digital Health

    This study aimed to provide a detailed analysis of potential risk factors prior to diagnosis using a large patient sample and a focus on health conditions identified in primary care


    The research team extracted anonymous health information from a database of nearly 40,000 Alzheimer's patients (20,214 patients in the UK, 1 January 1996 - 31 March 2020; 19,458 patients in France, January 1998 4-February 20, 2019), these patients were followed up for at least two years


    The research team analyzed three different periods before diagnosis to distinguish risk factors for Alzheimer's disease (10-15 years before diagnosis), early symptoms (2-10 years before diagnosis) and comorbid symptoms (2 years before diagnosis) )


    The results showed that, after statistical adjustment, 10 symptoms of Alzheimer's disease were significantly associated with Alzheimer's disease in patients in both countries in the 2-10 years before diagnosis, in other words, presumably early symptoms


    Major depressive disorder: associated with a 34% increased odds of AD diagnosis in UK patients; 73% increased odds of AD diagnosis in French patients


    Five symptoms remained significantly associated after multivariate analysis, including anxiety, depression, constipation, spondylosis, and memory loss


    In the time window of 10-15 years before diagnosis, none of the above symptoms were found to be significantly associated with Alzheimer's diagnosis


    In the 0-2 years before the diagnosis, a total of 21 symptoms were significantly related to the diagnosis of Alzheimer's disease, which may be comorbid symptoms of Alzheimer's disease


    Next, the research team compared the incidence of various health problems associated with Alzheimer's disease over time in the Alzheimer's disease group and the control group


    ▲In the AD cohort, the incidence of health problems significantly related to AD, the trend over time (Image source: Reference [1])

    The paper concludes that these results provide new evidence of underlying risk factors and early signs associated with Alzheimer's disease, which can be observed in primary care settings, and can be used for primary prevention and treatment of Alzheimer's disease.


    The research team is currently expanding the database, adding data from Sweden and Australia for further analysis based on the European Neurodegenerative Disease Research Project


    References

    [1] Thomas Nedelec, et al.


    [2] GBD 2019 Dementia Forecasting Collaborators.
    (2022).
    IEstimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.
    The Lancet Public Health, DOI: https:// doi.
    org/10.
    1016/S2468-2667(21)00249-8

    [3] Identification of new risk factors or early signs of Alzheimer's disease.
    Retrieved February 23, 2022 from https:// abridged)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.